SARS-CoV-2 immunization strategies to enhance protective immunity with reduced risk of antibody-dependent enhancement (ADE)
SARS-CoV-2 immunization strategies to enhance protective immunity with reduced risk of antibody-dependent enhancement (ADE)
批准号:
430618
负责人:
Archambault Denis
金额:
$45.37万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2020
资助国家:
加拿大
项目状态:
已结题
起止时间:
2020-05-01 至 2021-05-01
中文摘要
点击翻译按钮获取中文摘要
英文摘要
A pandemic of Severe Acute Respiratory Syndrome Coronavirus type 2 (SARS-CoV-2) that emerged from China late in 2019 is currently underway resulting in worldwide severe morbidity and mortality. Thus, a safe and effective vaccine is urgently needed to figh
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
COVID-19 Variant Supplement - SARS-CoV-2 immunization strategies to enhance protective immunity with reduced risk of antibody-dependent enhancement (ADE)
-
批准号:443273
-
项目类别:Operating Grants
-
资助金额:$3.64万
-
财政年份:2021
-
负责人:Archambault Denis
-
依托单位:
La portion C-terminale de la protéine P97 de Mycoplasma hyopneumoniae: une nouvelle molécule adjuvante à des fins vaccinales
-
批准号:295576
-
项目类别:Operating Grants
-
资助金额:$26.59万
-
财政年份:2013
-
负责人:Archambault Denis
-
依托单位:
海外基金